Maureen T Stewart
Biographic Data
| ID | 5417091 |
|---|---|
| NAME | Maureen T Stewart |
| GIVEN NAMES | Maureen T |
| FAMILY NAME | Stewart |
| SIGNATURE | STEWART M T |
| AFFILIATIONS | Boston University |
| ORCID | 0000-0002-5470-0307 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2002 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Provision of recommended treatment for stimulant use disorder in United States substance use treatment facilities
Expanding access to low‐barrier opioid use disorder treatment in non‐traditional settings
PURPOSE: Increasing utilization of medications that treat opioid use disorders (MOUD) remains an essential strategy to curb the opioid crisis nationwide, especially among rural areas where access can present challenges. Washington State expanded access to MOUD through its opioid treatment networks (OTN), which provide low-barrier access to MOUD in non-traditional settings with an emphasis on buprenorphine and rural locations. We examined changes …
Treatment for Comorbid Mental Health Disorders Among Patients Treated for Opioid Disorder
This study assessed whether delivery of opioid use disorder (OUD) treatment through a hub and spoke (HS) model is associated with better adherence to psychotropic medication treatment, compared to usual treatment. Washington State’s HS model required each network to include at least one mental health program, so we hypothesized that it would improve psychotropic medication adherence for people with both a mental health disorder (MHD) and an OUD. …
Coverage for Opioid Use Disorder Medications in Medicaid Managed Care
This cross-sectional study describes the distribution of state Medicaid managed care plans providing and managing opioid use disorder medication benefits to beneficiaries in 2023
Massachusetts Substance Use Disorder Treatment Organizations’ Perspectives on the Affordable Care Act
The Affordable Care Act (ACA) expanded insurance benefits and coverage for substance use disorder (SUD) treatment and encouraged delivery and payment reforms. Massachusetts passed a similar reform in 2006. This study aims to assess Massachusetts SUD treatment organizations' responses to the ACA. Organizational interviews addressing challenges of and responses to the ACA were conducted in person June-December 2014 with 31 leaders at 12 treatment o…
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014
Opioid use disorders (OUDs) are receiving significant attention in the U.S. as a public health crisis. Access to treatment for OUDs is essential and was expected to improve following implementation of the federal parity law and the Affordable Care Act. This study examines changes in coverage and management of treatments for OUDs (opioid treatment programs (OTPs) as a covered service benefit, buprenorphine as a pharmacy benefit) before, during, an…
Evaluating the Role of Patient Sample Definitions for Quality Indicators Sensitive to Nurse Staffing Patterns
BACKGROUND: Administrative data are an attractive data source for the construction of quality indicators to assess and monitor quality of nursing care in hospitals. Current approaches to constructing measures from discharge abstracts apply substantial restrictions to exclude patients at high risk or with preexisting conditions. This study evaluates whether broader sample definitions combined with risk adjustment would allow for larger samples and…
Nurse-Staffing Levels and the Quality of Care in Hospitals
BACKGROUND: It is uncertain whether lower levels of staffing by nurses at hospitals are associated with an increased risk that patients will have complications or die. METHODS: We used administrative data from 1997 for 799 hospitals in 11 states (covering 5,075,969 discharges of medical patients and 1,104,659 discharges of surgical patients) to examine the relation between the amount of care provided by nurses at the hospital and patients' outcom…
No prominent works on this page.
Nurse-Staffing Levels and the Quality of Care in Hospitals
BACKGROUND: It is uncertain whether lower levels of staffing by nurses at hospitals are associated with an increased risk that patients will have complications or die. METHODS: We used administrative data from 1997 for 799 hospitals in 11 states (covering 5,075,969 discharges of medical patients and 1,104,659 discharges of surgical patients) to examine the relation between the amount of care provided by nurses at the hospital and patients' outcom…
Evaluating the Role of Patient Sample Definitions for Quality Indicators Sensitive to Nurse Staffing Patterns
BACKGROUND: Administrative data are an attractive data source for the construction of quality indicators to assess and monitor quality of nursing care in hospitals. Current approaches to constructing measures from discharge abstracts apply substantial restrictions to exclude patients at high risk or with preexisting conditions. This study evaluates whether broader sample definitions combined with risk adjustment would allow for larger samples and…
Massachusetts Substance Use Disorder Treatment Organizations’ Perspectives on the Affordable Care Act
The Affordable Care Act (ACA) expanded insurance benefits and coverage for substance use disorder (SUD) treatment and encouraged delivery and payment reforms. Massachusetts passed a similar reform in 2006. This study aims to assess Massachusetts SUD treatment organizations' responses to the ACA. Organizational interviews addressing challenges of and responses to the ACA were conducted in person June-December 2014 with 31 leaders at 12 treatment o…
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014
Opioid use disorders (OUDs) are receiving significant attention in the U.S. as a public health crisis. Access to treatment for OUDs is essential and was expected to improve following implementation of the federal parity law and the Affordable Care Act. This study examines changes in coverage and management of treatments for OUDs (opioid treatment programs (OTPs) as a covered service benefit, buprenorphine as a pharmacy benefit) before, during, an…
Coverage for Opioid Use Disorder Medications in Medicaid Managed Care
This cross-sectional study describes the distribution of state Medicaid managed care plans providing and managing opioid use disorder medication benefits to beneficiaries in 2023
Provision of recommended treatment for stimulant use disorder in United States substance use treatment facilities
Expanding access to low‐barrier opioid use disorder treatment in non‐traditional settings
PURPOSE: Increasing utilization of medications that treat opioid use disorders (MOUD) remains an essential strategy to curb the opioid crisis nationwide, especially among rural areas where access can present challenges. Washington State expanded access to MOUD through its opioid treatment networks (OTN), which provide low-barrier access to MOUD in non-traditional settings with an emphasis on buprenorphine and rural locations. We examined changes …
Treatment for Comorbid Mental Health Disorders Among Patients Treated for Opioid Disorder
This study assessed whether delivery of opioid use disorder (OUD) treatment through a hub and spoke (HS) model is associated with better adherence to psychotropic medication treatment, compared to usual treatment. Washington State’s HS model required each network to include at least one mental health program, so we hypothesized that it would improve psychotropic medication adherence for people with both a mental health disorder (MHD) and an OUD. …
Opioid use disorder (5 works) · Opioid Use Disorder Treatment (5 works) · Medicine (4 works) · Opioid (4 works) · Substance Abuse Treatment and Outcomes (4 works) · Health care (3 works) · Healthcare Policy and Management (3 works) · Nursing (3 works) · Buprenorphine (2 works) · Business (2 works)